The medical imaging technology provider has contributed $16.8m to BioMedTech, a fund managed by life sciences-focused VC firm Truffle Capital.
Medical imaging technology producer Guerbet has made a €15m ($16.8m) equity investment in BioMedTech a France-based fund managed by life sciences-focused venture capital firm Truffle Capital.
BioMedTech is raising €200m that will be invested in roughly 12 France-based companies developing medical technology and biotech.
Truffle Capital has set five investment criteria for BioMedTech, which is seeking companies demonstrating the capability of developing life-changing technologies for patients, and those with the potential of becoming world leaders in their sectors within six…
